Without antibiotics, many of us would be dead already, and modern medicine would not exist.

Now, most antibiotics are redundant because of the spread of antibiotic resistance around the world.

By 2050, it is predicted that more people will die from resistant microbes, than will die from cancer and diabetes combined.

The most dangerous of these resistant bacteria are CRE* (see video ).

For the past forty years no new classes of antibiotic against CRE have been marketed.

Helperby Therapeutics is one of a small handful of companies which has a treatment for CRE at the clinical trials stage of development.

View the Helperby Therapuetics Pipeline

The spread of CRE (Carbapenem Resistant Klebsiella pneumoniae) into Europe

Green depicts outbreaks of CRE at the rate of less than 5% of Klebsiella, and red shows the areas which have outbreaks of more than 25% (artist's impression of Centre for Disease Dynamics, Economics & Policy data)

*Carbapenem Resistant Enterobacteriaceae.